Related Experiment Video
Updated: Jul 19, 2026
06:17
Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
An estrogen receptor basis for raloxifene action in bone
H U Bryant1, A L Glasebrook, N N Yang
1Endocrine Research Division, Lilly Research Laboratories, Indianapolis, IN 46285, USA.
Summary
Selective estrogen receptor modulators (SERMs) like raloxifene mimic estrogen
Area of Science:
- Bone biology and pharmacology
- Endocrinology
- Pharmacology
Background:
- Estrogens play a role in bone health by suppressing bone turnover.
- Selective estrogen receptor modulators (SERMs) exhibit similar effects to estrogen on bone.
- Raloxifene is a SERM with estrogen-like effects on bone and other tissues.
Purpose of the Study:
- To compare the bone-related effects of raloxifene and estrogen.
- To investigate the molecular mechanisms underlying raloxifene's action on bone.
- To elucidate the pharmacological similarities and differences between raloxifene and estrogen.
Main Methods:
- In vitro studies on osteoclast differentiation.
- In vivo studies using ovariectomized rat models.
- Analysis of signaling pathways, including IL-6 and TGF-beta3.
- Ligand-binding assays and crystal structure analysis of estrogen receptors.
Main Results:
- Both estrogen and raloxifene inhibit osteoclast activity and bone turnover.
- Raloxifene, like estrogen, inhibits longitudinal bone growth in rats.
- Estrogen and raloxifene modulate similar signaling pathways (IL-6, TGF-beta3).
- Raloxifene binds to estrogen receptors (ER alpha and ER beta) with high affinity.
Conclusions:
- Raloxifene acts as an estrogen mimetic in bone, preventing bone loss through an estrogen receptor-mediated mechanism.
- Raloxifene demonstrates a distinct pharmacological profile, acting as an antagonist in some tissues (mammary, uterus) but an agonist in others (bone, cardiovascular).
- Subtle differences in ligand:receptor complex conformation explain the varied pharmacological effects of SERMs compared to estrogen.
Related Concept Videos
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:26Secondary Messengers in Hormone Action
Water-soluble hormones cannot cross the plasma membrane, so they rely on protein receptors that span the membrane to trigger intracellular signaling pathways. These pathways then activate second messengers inside the cell, including cAMP or calcium ions.
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...